LCM
IBB icon

Laurion Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Laurion Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-443,100
Closed -$43.3M – 1729
2017
Q1 		$43.3M Buy
+443,100
New +$42.4M 0.33% 71

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Laurion Capital Management's IBB Position: Q1 2019 in Review

Laurion Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 17,399 shares — an estimated $1.68M sold.

Laurion Capital Management first reported a position in IBB in Q2 2017 and held it in 6 quarters. The position peaked at $1.68M in Q4 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

  • Laurion Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
  • Laurion Capital Management sold 17,399 iShares Biotechnology ETF shares in Q1 2019, an estimated $1.68M.
  • Laurion Capital Management first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 6 quarters.
  • Laurion Capital Management's iShares Biotechnology ETF position peaked at $1.68M in Q4 2018.
  • 670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.